Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Oncogene
|
August 27, 2020
The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen
Shixiong Wang, Venkata S Somisetty, Baoyan Bai, et al.
Breast Cancer Research and Treatment
|
July 26, 2020
Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer
Andliena Tahiri, Xavier Tekpli, Somisetty V Satheesh, et al.
Genome Research
|
March 12, 2010
A CTCF-independent role for cohesin in tissue-specific transcription
Dominic Schmidt, Petra C Schwalie, Caryn S Ross-Innes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 4, 2011
Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells
Kelly A Holmes, Antoni Hurtado, Gordon D Brown, et al.
Experimental Cell Research
|
May 19, 2009
Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis
Albert Santamaria-Martínez, Jordi Barquinero, Anna Barbosa-Desongles, et al.
Nature
|
November 14, 2008
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen
Antoni Hurtado, Kelly A Holmes, Timothy R Geistlinger, et al.
Cell Death Discovery
|
August 28, 2025
HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability
David Tena-Chaves, Inês Pontes-Gomes, José Ángel Palomeque, et al.
Nucleic Acids Research
|
September 18, 2016
CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions
Elisa Fiorito, Yogita Sharma, Siv Gilfillan, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
July 9, 2008
Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells
Antoni Hurtado, Tomàs Pinós, Anna Barbosa-Desongles, et al.
Plos One
|
May 23, 2014
Switch in FOXA1 status associates with endometrial cancer progression
Ingvild Løberg Tangen, Camilla Krakstad, Mari K Halle, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Oncogene
|
August 27, 2020
The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen
Shixiong Wang, Venkata S Somisetty, Baoyan Bai, et al.
Breast Cancer Research and Treatment
|
July 26, 2020
Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer
Andliena Tahiri, Xavier Tekpli, Somisetty V Satheesh, et al.
Genome Research
|
March 12, 2010
A CTCF-independent role for cohesin in tissue-specific transcription
Dominic Schmidt, Petra C Schwalie, Caryn S Ross-Innes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 4, 2011
Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells
Kelly A Holmes, Antoni Hurtado, Gordon D Brown, et al.
Experimental Cell Research
|
May 19, 2009
Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis
Albert Santamaria-Martínez, Jordi Barquinero, Anna Barbosa-Desongles, et al.
Nature
|
November 14, 2008
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen
Antoni Hurtado, Kelly A Holmes, Timothy R Geistlinger, et al.
Cell Death Discovery
|
August 28, 2025
HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability
David Tena-Chaves, Inês Pontes-Gomes, José Ángel Palomeque, et al.
Nucleic Acids Research
|
September 18, 2016
CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions
Elisa Fiorito, Yogita Sharma, Siv Gilfillan, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
July 9, 2008
Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells
Antoni Hurtado, Tomàs Pinós, Anna Barbosa-Desongles, et al.
Plos One
|
May 23, 2014
Switch in FOXA1 status associates with endometrial cancer progression
Ingvild Løberg Tangen, Camilla Krakstad, Mari K Halle, et al.
Page
of 3